DK3484853T3 - Fremgangsmåde til fremstilling af en polymorf form af 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamid - Google Patents

Fremgangsmåde til fremstilling af en polymorf form af 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamid Download PDF

Info

Publication number
DK3484853T3
DK3484853T3 DK17742277.1T DK17742277T DK3484853T3 DK 3484853 T3 DK3484853 T3 DK 3484853T3 DK 17742277 T DK17742277 T DK 17742277T DK 3484853 T3 DK3484853 T3 DK 3484853T3
Authority
DK
Denmark
Prior art keywords
cyanobenzoyl
methylbenzamide
pyrazol
cyclopropyl
amino
Prior art date
Application number
DK17742277.1T
Other languages
English (en)
Other versions
DK3484853T5 (da
Inventor
Osama Suleiman
Lucia Romero Perez
Cornelius Stephan Harlacher
Stewart Jones
Original Assignee
Mereo Biopharma 1 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mereo Biopharma 1 Ltd filed Critical Mereo Biopharma 1 Ltd
Publication of DK3484853T3 publication Critical patent/DK3484853T3/da
Application granted granted Critical
Publication of DK3484853T5 publication Critical patent/DK3484853T5/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK17742277.1T 2016-07-14 2017-07-13 Fremgangsmåde til fremstilling af en polymorf form af 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamid DK3484853T5 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1612238.4A GB201612238D0 (en) 2016-07-14 2016-07-14 Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-Yl]-n-cyclopropyl-4-methylbenzamide
PCT/GB2017/052055 WO2018011578A1 (en) 2016-07-14 2017-07-13 Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide

Publications (2)

Publication Number Publication Date
DK3484853T3 true DK3484853T3 (da) 2021-05-25
DK3484853T5 DK3484853T5 (da) 2021-09-06

Family

ID=56890595

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17742277.1T DK3484853T5 (da) 2016-07-14 2017-07-13 Fremgangsmåde til fremstilling af en polymorf form af 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamid

Country Status (19)

Country Link
US (1) US10995071B2 (da)
EP (1) EP3484853B9 (da)
JP (1) JP7094020B2 (da)
KR (1) KR102460533B1 (da)
CN (1) CN109415325B (da)
AU (1) AU2017294642B2 (da)
BR (1) BR112019000540A2 (da)
CA (1) CA3030617C (da)
DK (1) DK3484853T5 (da)
ES (1) ES2879608T3 (da)
GB (1) GB201612238D0 (da)
HU (1) HUE054686T2 (da)
IL (1) IL263900B (da)
MX (1) MX2019000384A (da)
PL (1) PL3484853T3 (da)
PT (1) PT3484853T (da)
RU (1) RU2765719C2 (da)
SG (1) SG11201811517SA (da)
WO (1) WO2018011578A1 (da)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69924480D1 (en) * 1998-05-05 2005-05-04 Hoffmann La Roche Pyrazolderivative als p-38 map kinase inhibitoren
PT1641764E (pt) 2003-06-26 2011-10-27 Novartis Ag Inibidores de p38 quinase a base de heterociclo de 5 elementos
PT2827860T (pt) * 2012-03-20 2016-12-20 Mereo Biopharma 1 Ltd Utilização de um derivado de pirazole no tratamento de exacerbações agudas da doença pulmonar obstructiva crónica
JP6741773B2 (ja) 2016-03-08 2020-08-19 メレオ バイオファーマ 1 リミテッド 炎症状態の急性増悪の治療のための投与レジメン
RU2713203C1 (ru) 2016-03-08 2020-02-04 Мерео Байофарма 1 Лимитед Режим дозирования при лечении острых обострений хронической обструктивной болезни легких

Also Published As

Publication number Publication date
RU2019103879A3 (da) 2020-08-14
KR20190027819A (ko) 2019-03-15
ES2879608T3 (es) 2021-11-22
EP3484853A1 (en) 2019-05-22
JP7094020B2 (ja) 2022-07-01
PL3484853T3 (pl) 2021-11-02
CA3030617A1 (en) 2018-01-18
US20190315694A1 (en) 2019-10-17
AU2017294642A1 (en) 2019-01-17
WO2018011578A1 (en) 2018-01-18
AU2017294642B2 (en) 2021-03-04
US10995071B2 (en) 2021-05-04
IL263900A (en) 2019-01-31
CN109415325A (zh) 2019-03-01
HUE054686T2 (hu) 2021-09-28
CN109415325B (zh) 2022-04-01
KR102460533B1 (ko) 2022-10-31
EP3484853B1 (en) 2021-04-21
JP2019521133A (ja) 2019-07-25
SG11201811517SA (en) 2019-01-30
CA3030617C (en) 2024-02-20
RU2765719C2 (ru) 2022-02-02
PT3484853T (pt) 2021-05-25
MX2019000384A (es) 2019-05-23
DK3484853T5 (da) 2021-09-06
EP3484853B9 (en) 2021-07-28
GB201612238D0 (en) 2016-08-31
RU2019103879A (ru) 2020-08-14
BR112019000540A2 (pt) 2019-04-24
IL263900B (en) 2022-04-01

Similar Documents

Publication Publication Date Title
DK3325443T3 (da) Fremgangsmåde til fremstilling af pridopidin
DK3152176T3 (da) Fremgangsmåde til fremstillingen af en cementforbindelse
DK3180331T3 (da) Polymorfer af selinexor
DK3287523T3 (da) Fremgangsmåde til sekretorisk fremstilling af protein
DK3411212T3 (da) Fremgangsmåde til fremstilling af en drivrem
DK3504295T3 (da) Fremgangsmåde til fremstilling af en brændstofkomponent
DK3529227T3 (da) Fremgangsmåde til fremstilling af diener
DK3165340T3 (da) Afstivningsfremgangsmåde til afstivning af en armeringskonstruktion
DK3295941T3 (da) Fremgangsmåde til fremstilling af form a af grapiprant
DK3262023T3 (da) Fremgangsmåde til fremstillingen af diener
SE1651513A1 (sv) Method for making a film comprising mfc
DK3535257T3 (da) Fremgangsmåde til oprensning af pyrazolpyridaziner
DK3265439T3 (da) Fremgangsmåde til fremstilling af 3-chlor-2-vinylphenylsulfonater
DK3507282T3 (da) Fremgangsmåde til fremstilling af indolcarboxamidforbindelser
DK3172757T3 (da) Fremgangsmåde til automatisk korrektion af astigmastisme
DK3523270T3 (da) Fremgangsmåde til fremstilling af cyclopropyl-substituerede acetophenoner
DK3247700T3 (da) Fremgangsmåde til fremstilling af en polyumættet ketonforbindelse
DK3484471T3 (da) Fremgangsmåde til fremstilling af en polymorf form af 3-[5-amino-4-(3- cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamid
DK3652187T3 (da) Forbedret fremgangsmåde til fremstilling af imetelstat
DK3311804T3 (da) Fremgangsmåde til fremstilling af kolloidosome mikrokapsler
DK3319924T3 (da) Fremgangsmåde til fremstilling af en plade
DK3081623T3 (da) En fremgangsmåde til fremstilling af oliebaserede komponenter
DK3356541T3 (da) Fremgangsmåde til fremstilling af l-methionin
DK3356540T3 (da) Fremgangsmåde til fremstilling af l-methionin
DK3484853T3 (da) Fremgangsmåde til fremstilling af en polymorf form af 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamid